Norfloxacină Atb

Norfloxacin, the active ingredient in Norfloxacină Atb, is a fluoroquinolone presented as a tablet for oral use. It is employed to treat bacterial infections of the urinary tract, prostate and gastrointestinal tract, and is indicated for uncomplicated infections in otherwise healthy adults.

GNH USA supplies Norfloxacină Atb as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable delivery across multiple markets. The company adheres to WHO‑GMP standards and provides full regulatory documentation for importers.

Norfloxacin is a fluoroquinolone antibacterial indicated for infections of specific organ systems. - Urinary tract infections: effective in eradicating susceptible Gram‑negative and some Gram‑positive bacteria, relieving symptoms and preventing recurrence. - Prostatitis: achieves bacterial clearance in the prostate tissue, reducing inflammation and clinical signs. - Gastrointestinal infections: treats susceptible enteric pathogens, aiding resolution of diarrhoea and abdominal discomfort.

Norfloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often transient. - Diarrhoea: loose stools that may be self‑limiting. - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or swelling, especially in the Achilles. - Peripheral neuropathy: tingling, numbness or burning sensations. - QT prolongation: cardiac rhythm changes detectable on ECG. - Severe allergic reactions: anaphylaxis, angioedema, or bronchospasm. - Clostridioides difficile colitis: persistent diarrhoea with abdominal pain.

Before prescribing norfloxacin, clinicians should consider several safety and handling precautions. - Renal impairment: adjust therapy or monitor renal function closely. - History of tendon disorders: avoid use in patients with prior tendon injury. - Concomitant QT‑prolonging drugs: assess risk of cardiac arrhythmias. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Age >65 years: increased susceptibility to CNS effects; monitor closely. - Store at below 25°C: keep in original container, protect from moisture and light.

Norfloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce absorption; separate dosing by at least 2 hours. - Warfarin: may enhance anticoagulant effect; monitor INR closely. - Cyclosporine: increased risk of nephrotoxicity; consider alternative therapy.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation. - Theophylline: potential for increased serum levels; monitor for toxicity. - Oral corticosteroids: may raise risk of tendon rupture; advise caution.